BINEX Co. Ltd Market Cap ($127.45 Million)

$127.45 Million USD · ₩188.06 Billion KRW · Rank #18105

Market Cap & Net Worth: BINEX Co. Ltd (053030)

BINEX Co. Ltd market cap. BINEX Co. Ltd (KQ:053030) has a market capitalization of $127.45 Million (₩188.06 Billion) as of November 3, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #18105 globally and #782 in its home market, demonstrating a -1.47% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying BINEX Co. Ltd's stock price ₩6030.00 by its total outstanding shares 31187800 (31.19 Million). Also see BINEX Co. Ltd operating cash flow efficiency for how efficiently the company converts equity into cash flow.

BINEX Co. Ltd Market Cap History (2015–2026)

BINEX Co. Ltd market cap history from 2015 to 2026. Data shows change from $342.40 Million to $127.45 Million (-8.72% CAGR). Check 053030 share price today for real-time trading data and today's change.

Index Memberships

BINEX Co. Ltd is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$208.91 Billion	0.06%	#288 of 1384
Kosdaq Composite Index KQ11	$208.91 Billion	0.06%	#288 of 1384

Weight: BINEX Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

BINEX Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how BINEX Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore BINEX Co. Ltd equity growth rate to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.00x

BINEX Co. Ltd's market cap is 0.00 times its annual revenue

Industry average: 0.00x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2015	$342.40 Million	$66.54 Billion	-$9.29 Billion	0.01x	N/A
2016	$358.25 Million	$80.92 Billion	-$3.00 Billion	0.00x	N/A
2017	$228.26 Million	$78.03 Billion	-$11.29 Billion	0.00x	N/A
2018	$193.60 Million	$104.04 Billion	$6.34 Billion	0.00x	0.03x
2019	$166.97 Million	$125.26 Billion	$8.50 Billion	0.00x	0.02x
2020	$561.15 Million	$132.98 Billion	$6.41 Billion	0.00x	0.09x
2021	$321.26 Million	$134.40 Billion	$19.09 Billion	0.00x	0.02x
2022	$244.12 Million	$156.68 Billion	$12.44 Billion	0.00x	0.02x
2023	$189.16 Million	$154.82 Billion	$4.67 Billion	0.00x	0.04x
2024	$387.63 Million	$130.05 Billion	-$35.07 Billion	0.00x	N/A

Competitor Companies of 053030 by Market Capitalization

Companies near BINEX Co. Ltd in the global market cap rankings as of November 3, 2026. Also see BINEX Co. Ltd total assets for a full breakdown of the balance sheet.

Key companies related to BINEX Co. Ltd by market ranking:

Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5071 globally with a market cap of $2.65 Billion USD ( ₩3.91 Trillion KRW).
ST Pharm Co.Ltd (KQ:237690): Ranked #8900 globally with a market cap of $916.61 Million USD ( ₩1.35 Trillion KRW).
NatureCell Co.Ltd (KQ:007390): Ranked #9610 globally with a market cap of $784.13 Million USD ( ₩1.16 Trillion KRW).
Oscotec Inc (KQ:039200): Ranked #10238 globally with a market cap of $694.16 Million USD ( ₩1.02 Trillion KRW).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#5071	Sam Chun Dang Pharm. Co. Ltd	KQ:000250	$2.65 Billion	₩182700.00
#8900	ST Pharm Co.Ltd	KQ:237690	$916.61 Million	₩72500.00
#9610	NatureCell Co.Ltd	KQ:007390	$784.13 Million	₩21800.00
#10238	Oscotec Inc	KQ:039200	$694.16 Million	₩36450.00

Market Capitalization of BINEX Co. Ltd (2015–2026)

Market capitalization of BINEX Co. Ltd from 2015 to today. Between 2015 and today, BINEX Co. Ltd's market cap moved from $342.40 Million to $ 127.45 Million, with a yearly change of -8.72%.

Year	Market Cap	Change (%)
2026	₩127.45 Million	-59.75%
2025	₩316.61 Million	-18.32%
2024	₩387.63 Million	+104.92%
2023	₩189.16 Million	-22.51%
2022	₩244.12 Million	-24.01%
2021	₩321.26 Million	-42.75%
2020	₩561.15 Million	+236.08%
2019	₩166.97 Million	-13.76%
2018	₩193.60 Million	-15.19%
2017	₩228.26 Million	-36.28%
2016	₩358.25 Million	+4.63%
2015	₩342.40 Million	--

End of Day Market Cap According to Different Sources

On Nov 2nd, 2026 the market cap of BINEX Co. Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$127.45 Million USD
MoneyControl	$127.45 Million USD
MarketWatch	$127.45 Million USD
marketcap.company	$127.45 Million USD
Reuters	$127.45 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About BINEX Co. Ltd

KQ:053030 Korea Pharmaceuticals

Market Cap

$127.45 Million

₩188.06 Billion KRW

Market Cap Rank

#18105 Global

#782 in Korea

Share Price

₩6030.00

Change (1 day)

-0.82%

52-Week Range

₩5740.00 - ₩16400.00

All Time High

₩36100.00